What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

Liposorber

Call Directions Website

LIPOSORBER therapy removes LDL-C and Lp(a) from the blood and is indicated for FH and FSGS patients.

11/04/2026

Did you know?

By selectively removing apoB-containing lipoproteins, LIPOSORBER helps eligible patients achieve significant lipid reductions during treatment and can reduce:
✅ LDL cholesterol by approximately 73-83%
✅ Lipoprotein(a) by approximately 53-76%
✅ Rates of coronary events by 72%

References:
1. Kaneka Medical America LLC.,2025 LIPOSORBER LA-15 Instructions for use in Familial Hypercholesterolemia (FH), Section IV.
2. Mabuchi H, Koizumi J, Shimizu M, et al. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Am J Cardiol. 1998;82(12):1489-1495.

For LIPOSORBER Indications for Use and other safety information, please visit:
https://www.liposorber.com/liposorber-safety-info

10/29/2026

Highlights from an amazing DFCon! ✨

A special thank you to Dr. Kazu Suzuki and Dr. John Evans for their outstanding collaborative presentation, “Elevated Lp(a) and Residual PAD Risk: Case Study Series of No Option PAD with CLTI and Elevated Lp(a).” We appreciate the opportunity to bring together experts, colleagues, and customers for meaningful discussions that advance patient care.

Thanks to everyone who joined us during our speaker dinner and visited our team throughout the conference. We’re grateful for the connections, conversations, and shared commitment to improving patient care.

dfcon26

10/28/2026

High cholesterol isn't always caused by lifestyle.

Familial Hypercholesterolemia (FH) is an inherited condition that can cause extremely high LDL cholesterol from birth.

For certain high-risk FH patients who do not achieve adequate LDL-C control despite maximum tolerated therapy, Liposorber may be an important treatment option.

Talk with your healthcare provider if:
✅ You were clinically diagnosed with FH
✅ Your LDL-C and/or Lp(a) remains severely elevated despite diet & medications
✅ You've experienced cardiovascular events/disease despite treatment

Early identification can save lives.

For LIPOSORBER Indications for Use and other safety information, please visit:
https://www.liposorber.com/liposorber-safety-info

10/21/2026

We're excited to return to AHA Scientific Sessions 2026 in Chicago, November 7-9!

As one of the largest and most well-attended cardiovascular conferences we participate in each year, AHA Scientific Sessions provides an invaluable opportunity to connect with healthcare professionals from across the country. We're looking forward to meeting with current Liposorber customers, sharing clinical insights, and networking with clinicians interested in learning more about therapeutic apheresis for patients with elevated Lp(a).

If you’re attending, be sure to stop by and meet the LIPOSORBER team.
📍 Chicago, IL
🗓️ November 7-9, 2026
(a)

10/16/2026

We are excited to announce that DFCon 2026 will be our first time exhibiting at this premier meeting dedicated to diabetic foot care and limb preservation!
The LIPOSORBER team will be headed to Anaheim, CA, on October 22-24, where we'll have the opportunity to connect with podiatrists, vascular surgeons, endocrinologists, wound care specialists, and other healthcare professionals committed to improving outcomes for patients at risk of limb loss.
As first-time exhibitors, we're looking forward to engaging with the limb preservation community, sharing insights, building new relationships, and learning from the experts advancing care in this important field.
If you'll be attending, be sure to stop by and meet the LIPOSORBER team. We can't wait to connect with you in Anaheim!

📍JW Marriott Anaheim Resort | Anaheim, CA
🗓️ October 22-24, 2026

10/14/2026

Apheresis isn't only used for cholesterol disorders.

LIPOSORBER is also FDA-authorized under a Humanitarian Device Exemption for eligible patients with primary Focal Segmental Glomerulosclerosis (FSGS), a rare kidney disease that can lead to serious kidney damage when standard treatments fail.

Awareness can help patients discover additional treatment options and connect with knowledgeable care teams sooner.

For eligible patients with drug-resistant or recurrent FSGS, studies have reported approximately 50% complete or partial remission following treatment with Liposorber as part of the overall management approach.

Learn about how LIPOSORBER can benefit patients with primary FSGS: liposorber.com/kidney-disease/liposorber-for-fsgs

For LIPOSORBER Indications for Use and other safety information, please visit:
https://www.liposorber.com/liposorber-safety-info

Reference: Muso E, et al. Immediate therapeutic efficacy of LDL apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study. Clin Exp Nephrol. 2015;19(3):379-386.

10/07/2026

💙 Happy National Physician Assistant Week!

This National Physician Assistant Week, we celebrate the incredible impact Physician Assistants have on patient care.

From educating patients and coordinating treatment plans to helping manage complex cardiovascular conditions, PAs are at the forefront of improving outcomes and enhancing patient experiences.

Thank you for your unwavering commitment to the patients and families you serve. The Liposorber team is proud to honor and celebrate you this week and beyond.

09/24/2026

What happens when healthy lifestyle choices and maximum medications still aren't enough to manage severe Familial Hypercholesterolemia (FH)? 🧬

FH Awareness Day is an opportunity to identify patients who may benefit from additional treatment options. For high-risk individuals with severe FH, dangerously elevated LDL-C or Lipoprotein(a) [Lp(a)] can persist despite best efforts.

That is where advanced cardiovascular treatment options come in. The LIPOSORBER® System performs targeted lipoprotein apheresis, selectively removing atherogenic lipoproteins directly from the bloodstream.

If you or a loved one is struggling to control severe FH, talk to your specialist about whether lipoprotein apheresis is right for your treatment plan.

🔗 For Indications for Use and Important Safety Information, please visit: liposorber.com/liposorber-safety-info

09/24/2026

September Updates: A Month of Awareness, Education & Patient Inspiration

In this issue of our monthly Newsletter, we highlight Apheresis and FH Awareness Day, plus we share Anthony's inspirational FH story

09/23/2026

❌ Myth: Lipoprotein apheresis treatment is too expensive and difficult to access.
✅ Fact: Kaneka offers a dedicated reimbursement team that works with treatment sites on coding, coverage, and operational support to help streamline access to LIPOSORBER treatment.

If you've been told that advanced treatment options are out of reach, know that support is available. Reimbursement advocates can help guide patients through the insurance process and connect them with resources to access LIPOSORBER treatment.

Talk to your healthcare team about available coverage and support resources.

For LIPOSORBER Indications for Use and other safety information, please visit: liposorber.com/liposorber-safety-info

Address

623 5th Avenue 27th FL
New York, NY
10022

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Telephone

(800)5263522

Website

http://www.liposorber.com/

Alerts

Be the first to know and let us send you an email when Liposorber posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.